Early-onset motor polyneuropathy associated with a novel dominant NAGLU mutation

Neurol Sci. 2023 Apr;44(4):1415-1418. doi: 10.1007/s10072-023-06607-0. Epub 2023 Jan 17.

Abstract

Introduction: NAGLU encodes N-acetyl-alpha-glucosaminidase, an enzyme that degrades heparan sulfate. Biallelic NAGLU mutations cause mucopolysaccharidosis IIIB, a severe childhood-onset neurodegenerative disease, while monoallelic mutations are associated to late-onset, dominantly inherited painful sensory neuropathy. However, to date, only one family with a dominant NAGLU-related neuropathy has been described.

Case report: Here we describe a patient with early-onset motor polyneuropathy harboring a novel monoallelic NAGLU mutation. We found reduced NAGLU enzymatic activity thus corroborating the pathogenic role of the new variant.

Discussion: Our report represents the second ever described case with dominant NAGLU-related neuropathy and the first case with early-onset motor symptoms. We underlie the importance of a thorough clinical description of this probably underestimated new clinical entity.

Keywords: NAGLU; Neuropathy.

Publication types

  • Case Reports

MeSH terms

  • Child
  • Hereditary Sensory and Autonomic Neuropathies*
  • Humans
  • Mucopolysaccharidosis III* / diagnosis
  • Mucopolysaccharidosis III* / genetics
  • Mucopolysaccharidosis III* / pathology
  • Mutation / genetics
  • Neurodegenerative Diseases*
  • Peripheral Nervous System Diseases*
  • Polyneuropathies* / genetics

Substances

  • alpha-N-acetyl-D-glucosaminidase